http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30279385

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural
endingPage 22853
issn 0021-9258
issueIdentifier 27
pageRange 22838-22853
publicationName The Journal of biological chemistry
startingPage 22838
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1a7115803d3a23740457918a672348a3
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9aebfce7e910c07ed078412d3874e06d
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ba33558e10999ca6b645e415a999e982
bibliographicCitation Zimmermann M, Arachchige-Don AS, Donaldson MS, Dallapiazza RF, Cowan CE, Horne MC. Elevated Cyclin G2 Expression Intersects with DNA Damage Checkpoint Signaling and Is Required for a Potent G2/M Checkpoint Arrest Response to Doxorubicin. Journal of Biological Chemistry. 2012 Jun;287(27):22838–53. doi: 10.1074/jbc.m112.376855.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92fd3a4c09c78dcd4fd9a6797db4357d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7cdf07726a3a83f0a39752c71b67c9fc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9005-3795
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70049ba78d8b146f15d60ce6c5910741
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0bececbdf7efabbc4c49584708f5d776
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_683bfc5766ea4464745298737a25d5d0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d2eda54c5ae0c18a6b2e872749a09980
date 2012-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/22589537
https://doi.org/10.1074/jbc.m112.376855
https://pubmed.ncbi.nlm.nih.gov/PMC3391138
isPartOf https://portal.issn.org/resource/ISSN/0021-9258
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4559
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Elevated Cyclin G2 Expression Intersects with DNA Damage Checkpoint Signaling and Is Required for a Potent G2/M Checkpoint Arrest Response to Doxorubicin
discusses http://id.nlm.nih.gov/mesh/M0529102
http://id.nlm.nih.gov/mesh/M0024065
http://id.nlm.nih.gov/mesh/M0374857
http://id.nlm.nih.gov/mesh/M0001348
http://id.nlm.nih.gov/mesh/M0248389
http://id.nlm.nih.gov/mesh/M0028197
http://id.nlm.nih.gov/mesh/M0406100
http://id.nlm.nih.gov/mesh/M0481741
http://id.nlm.nih.gov/mesh/M0481742
http://id.nlm.nih.gov/mesh/M0026339
http://id.nlm.nih.gov/mesh/M0473042
http://id.nlm.nih.gov/mesh/M0521452
http://id.nlm.nih.gov/mesh/M0024670
http://id.nlm.nih.gov/mesh/M0245645
http://id.nlm.nih.gov/mesh/M0024739
http://id.nlm.nih.gov/mesh/M0028143
http://id.nlm.nih.gov/mesh/M0528980
http://id.nlm.nih.gov/mesh/M0024671
http://id.nlm.nih.gov/mesh/M0006784
http://id.nlm.nih.gov/mesh/M0266276
http://id.nlm.nih.gov/mesh/M0006678
http://id.nlm.nih.gov/mesh/M0489263
http://id.nlm.nih.gov/mesh/M0029601
http://id.nlm.nih.gov/mesh/M0451044
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D056767Q000235
http://id.nlm.nih.gov/mesh/D002455Q000502
http://id.nlm.nih.gov/mesh/D004317Q000494
http://id.nlm.nih.gov/mesh/D004249Q000502
http://id.nlm.nih.gov/mesh/D016195Q000502
http://id.nlm.nih.gov/mesh/D015398Q000187
hasSubjectTerm http://id.nlm.nih.gov/mesh/D017346Q000378
http://id.nlm.nih.gov/mesh/D017346Q000235
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D016203
http://id.nlm.nih.gov/mesh/D004268Q000378
http://id.nlm.nih.gov/mesh/D000903Q000494
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D018844
http://id.nlm.nih.gov/mesh/D045325
http://id.nlm.nih.gov/mesh/D018797Q000235
http://id.nlm.nih.gov/mesh/D056767Q000378
http://id.nlm.nih.gov/mesh/D002455Q000187
http://id.nlm.nih.gov/mesh/D019926Q000378
http://id.nlm.nih.gov/mesh/D009369Q000473
http://id.nlm.nih.gov/mesh/D009369Q000503
http://id.nlm.nih.gov/mesh/D056744Q000378
http://id.nlm.nih.gov/mesh/D009369Q000188
http://id.nlm.nih.gov/mesh/D064007
http://id.nlm.nih.gov/mesh/D064447
http://id.nlm.nih.gov/mesh/D016195Q000187
http://id.nlm.nih.gov/mesh/D025521Q000378
http://id.nlm.nih.gov/mesh/D025521Q000235
http://id.nlm.nih.gov/mesh/D004268Q000235
http://id.nlm.nih.gov/mesh/D018797Q000378
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D041681
http://id.nlm.nih.gov/mesh/D018816Q000502
http://id.nlm.nih.gov/mesh/D034741Q000235
http://id.nlm.nih.gov/mesh/D015689Q000378
http://id.nlm.nih.gov/mesh/D018816Q000187
http://id.nlm.nih.gov/mesh/D015398Q000502
http://id.nlm.nih.gov/mesh/D016159Q000378
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e4b3f1f02e963a9dfe21c787e4c6768a
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5d8f94598af1b5110c615f34697fe502
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_52a517e173e6fa70285ded085be0d86f
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3688789958c37a07e00d8d1f8e9a29b4
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2328a6aec9ceab6815d57e097f19c45c
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.13.3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f1b2452da84551fc91db93425b6a20d9
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a423d85fa652b3ac7e8f59032ac788b2

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127476202

Total number of triples: 103.